| Financial Year |
March 31 2023 |
| Monetary Funds |
3,103,233,219.21 |
| Held-for-trading Financial Assets |
20,626,228.89 |
| Notes Receivable |
52,869,104.42 |
| Accounts Receivable |
1,051,072,477.67 |
| Advances to Suppliers |
1,199,610.40 |
| Other Receivables |
198,694,353.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,926,376,349.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
49,604,734.92 |
| Total Current Assets |
11,769,759,444.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,252,632,260.59 |
| Investment Properties |
403,126,911.48 |
| Fixed Assetes |
894,308,827.68 |
| Under-construction Projects |
158,403,262.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
68,446,006.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
50,568,639.54 |
| Deferred Income Tax Assets |
98,816,696.04 |
| Other Non-Current Assets |
570,336,908.73 |
| Sub-Total of Non-Current Assets |
3,580,536,702.80 |
| Total Assets |
15,350,296,147.14 |
| Short-Term Loans |
1,336,442,850.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,168,178.20 |
| Accounts Payable |
6,067,373,903.31 |
| Accounts Received In Advance |
737,645.71 |
| Employee Compensation Payable |
18,441,701.91 |
| Taxes Payable |
584,576,008.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
239,672,884.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
506,610,251.57 |
| Other Current Liabilities |
96,767,134.79 |
| Sub-Total of Current Liabilities |
9,568,708,149.86 |
| Long-term Loans |
1,123,317,099.95 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
33,677,521.93 |
| Deferred Income Tax Liabilities |
29,784,107.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,241,390,709.10 |
| Total Liabilities |
10,810,098,858.96 |
| Paid-In Capital(Or Share Stock) |
1,102,500,000.00 |
| Capital Surplus |
-- |
| Surplus Reserve |
446,840,677.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,638,512,698.59 |
| Minority Stockholder's Interest |
285,164,565.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,255,032,722.36 |
| Owner's Equity（Stockholder's Equity） |
4,540,197,288.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,350,296,147.14 |
